U.S. Retail Distributors Stock News

NYSE:WH
NYSE:WHHospitality

How New Leadership, Debt Issuance and Tech Upgrades At Wyndham (WH) Has Changed Its Investment Story

In late February and early March 2026, Wyndham Hotels & Resorts appointed Amit Sripathi as Chief Financial Officer, named David Wilner Chief Development Officer – North America, completed a US$650 million 5.625% senior notes offering due 2033, and rolled out upgraded group booking technology powered by Groups360. These leadership moves, balance sheet actions, and technology enhancements collectively highlight Wyndham’s focus on disciplined capital allocation, franchise-driven growth, and...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Is Astrana Health (ASTH) Still Attractive After The Recent 28% Weekly Price Jump

Wondering if Astrana Health at around US$25.59 is offering good value right now, or if the recent excitement has already been priced in. The share price has moved sharply in the short term, with a 28.3% return over the last 7 days and 14.7% over the past month, compared with a more muted 1.5% year to date and a 5.9% decline over the last year. These moves come as Astrana Health continues to attract attention in the healthcare space, where investors are weighing its role in a shifting care...
NYSE:OSK
NYSE:OSKMachinery

Oshkosh (OSK) Valuation Check After New Defense Partnership And Recent Share Price Momentum

Oshkosh (OSK) is back in focus after Oshkosh Defense agreed to a public private partnership with the Marine Depot Maintenance Command, aimed at using advanced manufacturing to speed part production for critical military fleets. See our latest analysis for Oshkosh. The Oshkosh Defense partnership arrives after a strong run, with the share price at US$166.99 and a 30 day share price return of 11.71%, alongside a 1 year total shareholder return of 76.71% that points to strong recent momentum. If...
NasdaqGS:CALM
NasdaqGS:CALMFood

Cal Maine Expands Indiana Egg Operations As Valuation Gap Draws Attention

Cal-Maine Foods (NasdaqGS:CALM) has completed the acquisition of Creighton Brothers LLC and Crystal Lake LLC. The deal expands Cal-Maine's shell egg, egg products, and prepared foods operations into Indiana. The transaction adds production capacity and internal supply chain resources across conventional and specialty egg categories. For you as an investor, this move adds another piece to the Cal-Maine story as the company increases its presence across the U.S. egg market. NasdaqGS:CALM is a...
NYSE:RKT
NYSE:RKTDiversified Financial

How Rocket’s Revenue Growth Yet Full-Year Loss At Rocket Companies (RKT) Has Changed Its Investment Story

In late February, Rocket Companies reported past fourth-quarter 2025 revenue of US$2,692 million and full-year revenue of US$6,695 million, but moved from prior-year profit to a full-year net loss of US$68 million as higher expenses weighed on results. The past-year performance highlights a tension between strong top-line growth and pressure on profitability, as acquisition-related and other costs offset revenue gains and raised fresh questions about Rocket’s path to stronger margins. We’ll...
NasdaqCM:SERV
NasdaqCM:SERVHospitality

Assessing Serve Robotics (SERV) Valuation After Recent Share Price Volatility

Why Serve Robotics is drawing attention now Serve Robotics (SERV) has been catching investor attention after recent share price swings, with the stock showing mixed short term performance and a wide gap between its latest close and analyst expectations. See our latest analysis for Serve Robotics. At a share price of $9.84, Serve Robotics has seen a 2.07% 1 day share price return but a 24.31% 90 day share price decline, while its 1 year total shareholder return of 18.84% points to earlier...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed’s Terahertz and Quantum AI Push Might Change The Case For Investing In Lockheed Martin (LMT)

In recent weeks, Teradar announced it completed a US$1.90 million U.S. Army SBIR Phase II contract, testing next-generation terahertz sensing with Lockheed Martin, while Xanadu revealed a quantum machine learning research initiative with the company as conflicts in the Middle East drove heightened demand for its defense systems. Together, these developments underscore how Lockheed Martin is simultaneously deepening its role in current military operations and pushing into advanced sensing and...
NYSE:IT
NYSE:ITIT

Gartner Results Prompt Rethink On Valuation Debt And Governance

Gartner (NYSE:IT) reported strong Q4 results alongside its first investment-grade bond issuance. The company completed a significant share repurchase program in conjunction with these results. Gartner added two new directors to its board, expanding its governance bench. Gartner enters this news cycle with its shares at $166.9 and a mixed recent track record, including an 11.8% gain over the past week, a 29.6% decline year to date, and a 66.0% decline over the past year. For investors, the...
NYSE:IQV
NYSE:IQVLife Sciences

Why IQVIA (IQV) Is Up 9.9% After Mixed Q4 Results and AI-Linked Outlook Reset

IQVIA Holdings’ recent fourth-quarter results showed 10.3% revenue growth, a larger R&D backlog, and a strong book-to-bill ratio, prompting several analysts to reaffirm positive ratings while adjusting their expectations due to AI-related challenges and business re-segmentation. At the same time, rising analyst attention, ongoing executive conference appearances, and insider share sales alongside higher estimated 2025 CEO compensation highlight how IQVIA’s leadership, incentives, and capital...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Assessing Recursion Pharmaceuticals (RXRX) Valuation After Earnings Jump And New Equity Offering Plans

Why Recursion’s latest earnings and capital plans matter Recursion Pharmaceuticals (RXRX) just posted its fourth quarter and full year 2025 results, showing much higher quarterly sales and revenue alongside a smaller quarterly net loss, and paired those numbers with fresh equity offering plans. The company reported fourth quarter sales of US$35.35 million and revenue of US$35.54 million, compared with US$4.51 million and US$4.55 million a year earlier, while quarterly net loss narrowed to...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet (FTNT) Is Up 7.0% After Stronger 2026 Billings Outlook Amid Margin Debate

In recent weeks, Fortinet reported quarterly earnings that exceeded consensus expectations and issued a fiscal 2026 billings growth outlook above prior forecasts, while also addressing margin pressures and hardware-model risks highlighted by JPMorgan and Wells Fargo. At the same time, Fortinet has maintained strong free cash flow generation and attracted a wide spread of analyst opinions, underscoring the debate around its hardware-centric model, evolving service mix, and exposure to...
NasdaqCM:RIOT
NasdaqCM:RIOTSoftware

Riot Platforms Reshapes Story With AMD Deal And Data Center Push

Riot Platforms (NasdaqCM:RIOT) is shifting its focus toward data center development and high performance computing, building on its acquisition of the Rockdale site. The company has entered into a 10 year lease agreement with AMD, positioning the Rockdale site as a hub for AI and high performance computing workloads. Riot has appointed a new CFO and outlined plans for greater vertical integration across its infrastructure efforts. Riot Platforms, known for its bitcoin mining operations, is...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Sizing Up Ondas (ONDS) After Its 10x One Year Share Price Surge

If you are wondering whether Ondas is still priced attractively after its recent run, this article will help you size up where the stock stands today. The share price closed at US$10.51, with a small 7 day gain of 2.0%, a 30 day return of 1.2% decline, a year to date return of 4.6% decline, and a very large 1 year return that is well over 10x. That kind of move tends to follow meaningful company updates, partnerships, financings, or regulatory milestones that change how investors think about...
NasdaqGM:ARCT
NasdaqGM:ARCTBiotechs

Arcturus Therapeutics Holdings ARCT Q4 Revenue Slide To US$7.2 Million Tests Growth Narrative

Arcturus Therapeutics Holdings (ARCT) has just posted its FY 2025 numbers with fourth quarter revenue of US$7.2 million and a basic EPS loss of US$1.03, alongside net income excluding extra items showing a US$29.1 million loss. Trailing twelve month revenue came in at US$82.0 million against a TTM EPS loss of US$2.40 and a US$65.8 million net loss. Over recent quarters the company has seen quarterly revenue move from US$29.4 million in Q1 2025 to US$28.3 million in Q2, US$17.2 million in Q3...
NYSE:MATX
NYSE:MATXShipping

How Matson’s (MATX) New No-Cost Cargo Security Partnership May Reshape Its Competitive Edge

In late February 2026, Matson, Inc. reported fourth-quarter 2025 revenue of US$851.9 million and net income of US$143.1 million, affirmed a US$0.36 per-share dividend, issued guidance for lower first-quarter 2026 operating income versus the prior year, and projected full-year 2026 operating income approaching 2025 levels. On March 2, 2026, Matson announced a partnership with BNSF Railway and War-Lok to launch a two-layer cargo security program, using War-Lok devices and lower-well railcar...
NYSE:KEX
NYSE:KEXShipping

A Look At Kirby (KEX) Valuation After Sustained Share Price Momentum

Kirby stock snapshot and recent performance Kirby (KEX) shares recently closed at $133.52, with the stock showing mixed short term moves, including a 0.2% decline over the past day and a 2.6% gain over the past week. Over longer periods, Kirby has recorded gains of 11.8% in the past month and 19.6% in the past 3 months, with total return figures of 19.3% year to date and 33.9% over the past year. See our latest analysis for Kirby. For investors, the key takeaway is that Kirby’s recent 1 month...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Shelf Registration Highlights Role In Expanding Semiconductor IP Market

Cadence Design Systems (NasdaqGS:CDNS) has filed a significant shelf registration, giving it the flexibility to issue securities in the future. The company is being highlighted as a key player in the expanding semiconductor IP market, where demand for licensed chip designs is increasing. These developments are drawing investor attention to Cadence's capital options and its role in a growing segment of the semiconductor ecosystem. Cadence Design Systems develops software and intellectual...
NYSE:IFF
NYSE:IFFChemicals

Assessing International Flavors & Fragrances (IFF) Valuation After Recent Share Price Momentum

Recent performance puts International Flavors & Fragrances (IFF) back in focus International Flavors & Fragrances (IFF) has drawn fresh attention after a mixed stretch of returns, with gains over the past month and past 3 months contrasting with weaker 1 year and multi year performance. See our latest analysis for International Flavors & Fragrances. With the share price at US$78.19, International Flavors & Fragrances has a 30 day share price return of 12.1% and a 90 day share price return of...
NYSE:IBM
NYSE:IBMIT

A Look At IBM’s (IBM) Valuation After Recent Mixed Share Price Performance

IBM’s recent performance and business profile International Business Machines (IBM) has recently seen mixed share performance, with a gain of 1.9% over the past day and 5.3% over the past week, set against weaker returns over the past month and past 3 months. The company reports annual revenue of US$67.5b and net income of US$10.6b, with both revenue and net income growth figures provided on an annual basis. These numbers help frame IBM as a large, globally diversified technology and services...
NYSE:LUMN
NYSE:LUMNTelecom

Will Lumen’s AI Twin Network Initiative with Blue Planet Redefine Lumen Technologies' (LUMN) Narrative?

In February 2026, Blue Planet announced that Lumen Technologies began adopting its OSS-native AI agents and Blue Planet AI Studio to automate and enhance network operations across multiple domains. A distinctive element of this rollout is Lumen’s plan to pair agentic AI with a digital network twin, aiming for more autonomous, real-time network management and improved customer experiences. Next, we’ll examine how Lumen’s use of Blue Planet’s AI Studio to automate network management workflows...
NYSE:REX
NYSE:REXOil and Gas

Why REX American Resources (REX) Is Up 6.8% After 21st Straight Profitable Quarter And Earnings Beat

In its fiscal third quarter 2025 results released prior to today, REX American Resources reported net income per share of US$0.71, marking its 21st consecutive profitable quarter and underscoring its focus on ethanol production and alternative energy initiatives. This extended profitability streak, combined with stronger-than-expected quarterly earnings, highlights how REX’s emphasis on renewable fuels and specialty ingredient solutions is supporting resilient operations and attracting...
NYSE:LEG
NYSE:LEGConsumer Durables

A Look At Leggett & Platt (LEG) Valuation After Recent Share Price Weakness

What Leggett & Platt’s Recent Performance Means For Investors Leggett & Platt (LEG) has been back on investors’ radar after a mixed stretch in the share price, with a recent month return showing a 7.9% decline while the past year total return sits around 32%. See our latest analysis for Leggett & Platt. Recent trading has been softer, with a 30 day share price return of 7.9% and a 7 day share price return of 1.8%. The 1 year total shareholder return of 32.1% contrasts with a 5 year total...
NasdaqGM:SGC
NasdaqGM:SGCLuxury

Superior Group Of Companies (SGC) Margin Compression Challenges Bullish Earnings Narratives

Latest FY 2025 Results Set the Stage for a Margin Story at Superior Group of Companies (SGC) Superior Group of Companies (SGC) closed FY 2025 with fourth quarter revenue of US$146.6 million and basic EPS of US$0.24, alongside trailing twelve month revenue of US$566.2 million and EPS of US$0.47 that frame the full year picture. Over recent quarters, the company has seen revenue move from US$145.4 million and EPS of US$0.13 in Q4 2024 to US$137.1 million and an EPS loss of US$0.05 in Q1 2025,...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

Is It Time To Reassess United Therapeutics (UTHR) After Its Recent Share Price Volatility

If you are trying to figure out whether United Therapeutics at around US$490 per share is still offering value, you are in the right place. The stock has had a mixed patch recently, with a 7 day return of an 8.4% decline, a 30 day gain of 3.2%, a year to date return of a 1.3% decline, while the 1 year return sits at 57.6% and the 3 year and 5 year returns are 120.2% and 207.0% respectively. These moves come as United Therapeutics continues to attract attention in the pharmaceuticals and...